PlainRecalls
CriticalClass ITerminated

FDA Drug recall · Reported January 26, 2022

SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24.

Microbial Contamination of Non-Sterile Product

Recall #
D-0377-2022
Affected scope
87,840 unit dose cups
Initiated
December 21, 2021
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

Lohxa, LLC recalled SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg… - a critical-severity action.

SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg… was recalled by Lohxa, LLC in January 26, 2022. Reason: Microbial Contamination of Non-Sterile Product. Check the official notice for the remedy. Verify recall #D-0377-2022 with the FDA Drug before acting.

The recall

Lohxa, LLC issued this critical-severity FDA Drug recall-Microbial Contamination of Non-Sterile Product.

Critical
severity level
88K units
affected scope
Class I
classification
January 26, 2022
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0377-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0377-2022) was formally reported on January 26, 2022, with the manufacturer initiating the action on December 21, 2021. It is classified under Critical severity (Class I), with a current status of Terminated. Lohxa, LLC is listed as the recalling firm, operating out of Worcester, MA. Federal records list the affected scope as 87,840 unit dose cups.

The documented reason for this recall is: Microbial Contamination of Non-Sterile Product Distribution data in the federal record shows the product reached: Product was distributed to one wholesale who further distributed the product nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,287 drugs & medications recalls on record

-50005001,0001,5002,000 2006201220152018202120242026 263
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Critical

Affected scope

87,840 unit dose cups

Related Recalls

6

5 from same agency

Product description

SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24.

Reason for recall

Microbial Contamination of Non-Sterile Product

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Critical (Class I)
Status Terminated
Recall number D-0377-2022
Date reported January 26, 2022
Date initiated December 21, 2021
Recalling firm Lohxa, LLC
Firm location Worcester, MA
Affected scope 87,840 unit dose cups
Distribution Product was distributed to one wholesale who further distributed the product nationwide in the USA

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

87,840 unit dose cups units affected - limited or regional distribution scale.

Regional (<10K units) -
Multi-state (10K – 100K units) ✓ This recall
Large-scale (100K – 1M units) -
Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0377-2022) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24.. Recalled by Lohxa, LLC. Units affected: 87,840 unit dose cups.
Why was this product recalled?
Microbial Contamination of Non-Sterile Product
Which agency issued this recall?
This recall was issued by the FDA Drug on January 26, 2022. Severity: Critical. Recall number: D-0377-2022.
Where was the recalled product distributed?
Distribution: Product was distributed to one wholesale who further distributed the product nationwide in the USA.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0377-2022) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →

Browse all Drugs & Medications recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported January 26, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.